Combating Prescription Drug Abuse Act

**see addendum pageImportation of prescription drugs (H.R. 3715, S. 2549) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.800 & S.806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R.1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R.4709, S.1277, S.1657, H.R.3392, H.R.4096 & S. 2862 legislation to prevent and reduce prescription drug abuse. H.R. 4190, Provide for coverage under Medicare program of pharmicist services

Client expense: $570,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse, (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621); Counterfeit Drugs; Importation of Prescription Drugs

Client expense: $257,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), pharmacy dispensing fees, drug safety, prescription drug diversion and abuse, drug shortages, supply chain, Medicare Sustainable Growth Rate, Medicaid reimbursement, and provider status S. 557 - Medication Therapy Management Empowerment Act of 2013 H.R. 1024 - Medication Therapy Management Empowerment Act of 2013 H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013 S. 1277 - Combating Prescription Drug Abuse Act H.R. 4190 - Improved Patients' Access to Pharmacist Services

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.800 & S.806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R.1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R.4709, S.1277, S.1657, H.R.3392, H.R.4096 & S. 2862 legislation to prevent and reduce prescription drug abuse. H.R. 4190, Provide for coverage under Medicare program of pharmicist services

Client expense: $360,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715, S. 2549)

Client expense: $361,413 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013 S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act H.R.3204 - Drug Quality and Security Act H.R. 4437 - Generic Drug Pricing Fairness Act

Client expense: $480,000 · Firm income: Not reported

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715, S. 2549)

Client expense: $361,413 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

**see addendum pageImportation of prescription drugs (H.R. 3715, S. 2549) Drug Shortages and Gray Market (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), pharmacy dispensing fees, drug safety, prescription drug diversion and abuse, drug shortages, supply chain, Medicare Sustainable Growth Rate, Medicaid reimbursement, and provider status S. 557 - Medication Therapy Management Empowerment Act of 2013 H.R. 1024 - Medication Therapy Management Empowerment Act of 2013 H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013 S. 1277 - Combating Prescription Drug Abuse Act H.R. 4190 - Improved Patients' Access to Pharmacist Services

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation and regulation related to medical licensure, telemedicine, medical regulations, license portability, and other matters that might affect state-based health regulation. Development of state compact for licensure S.1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013 (PRIME ACT) H.R.2305 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013 (PRIME ACT) H.R. 3077 - The TELE-MED Act of 2013 S. 1277 - Combating Prescription Drug Abuse Act H.R. 2484 - Conrad State 30 and Physician Access Act H.R. 3750 - Telehealth Modernization Act of 2013 potential legislation: Telehealth Promotion Act of 2014

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.800 & S.806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R.1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. H.R.4709, S.1277, S.1657, H.R.3392 & H.R.4096 legislation to prevent and reduce prescription drug abuse.H.R. 4190, Provide for coverage under Medicare program of pharmicist services

Client expense: $350,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageImportation of prescription drugs (H.R. 3715) Drug Shortages and Gray Market (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2437), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse, (S. 348, S. 1277, H.R. 4069, H.R. 4709), Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715)

Client expense: $233,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013 S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act H.R.3204 - Drug Quality and Security Act H.R. 4437 - Generic Drug Pricing Fairness Act

Client expense: $640,000 · Firm income: Not reported

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), pharmacy dispensing fees, drug safety, prescription drug diversion and abuse, drug shortages, supply chain, Medicare Sustainable Growth Rate, Medicaid reimbursement, and provider statusS. 557 - Medication Therapy Management Empowerment Act of 2013 H.R. 1024 - Medication Therapy Management Empowerment Act of 2013 H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013 S. 1277 - Combating Prescription Drug Abuse Act H.R. 4190 - Improved Patients' Access to Pharmacist Services

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE

Legislation and regulation related to medical licensure, telemedicine, medical regulations, license portability, and other matters that might affect state-based health regulation. Development of state compact for licensureS.1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013 (PRIME ACT) H.R.2305 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013 (PRIME ACT) H.R. 3077 - The TELE-MED Act of 2013 S. 1277 - Combating Prescription Drug Abuse Act H.R. 2484 - Conrad State 30 and Physician Access Act H.R. 3750 - Telehealth Modernization Act of 2013 potential legislation: Telehealth Promotion Act of 2014

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. S. 1277, S. 1657, H.R. 3392 & H.R. 4096 legislation to prevent and reduce prescription drug abuse.H.R. 4190, Provide for coverage under Medicare program of pharmicist services

Client expense: $420,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act H.R.3204 - Drug Quality and Security Act H.R. 4437 - Generic Drug Pricing Fairness Act

Client expense: $740,000 · Firm income: Not reported

**see addendum pageImportation of prescription drugs (H.R. 3715) Drug Shortages (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069), Hydrocodone Rescheduling (H.R. 1285, S. 621, and NPRM Docket No. DEA-389), Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715)

Client expense: $267,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation and regulation related to medical licensure, telemedicine, medical regulations, license portability, and other matters that might affect state-based health regulation. S.1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013 (PRIME ACT) H.R.2305 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013 (PRIME ACT)H.R. 3077 - The TELE-MED Act of 2013 S. 1277 - Combating Prescription Drug Abuse Act H.R. 2484 - Conrad State 30 and Physician Access Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. S. 1277, S. 1657 & H.R. 3392 legislation to prevent and reduce prescription drug abuse.H.R. 1919, H.R. 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding. Legislation pertaining to drug manufacturing shortages.

Client expense: $410,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageImportation of prescription drugs (H.R. 3715) Drug Abuse (S. 348, S. 1277) Hydrocodone Rescheduling (H.R. 1285, S. 621) Drug Shortages - Gray Market (H.R. 1958) Rx Pedigree (S. 959, S. 957, H.R.1919, H.R. 2186; H.R. 3204 - PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act H.R.3204 - Drug Quality and Security Act

Client expense: $480,000 · Firm income: Not reported

S. 621 and HR 1285: Safe Prescribing Act of 2013; Public Law 113-54: Drug Quality and Security Act; S. 1277: Combating Prescription Drug Abuse Act; issues relating to general drug abuse.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 806, H.R. 800 & H.R. 1416 relating to Average Sales Price; S. 1871 & H.R. 2810 relating to the Medicare sustainable growth rate PHA; S. 621 and HR 1285-Safe Prescribing Act of 2013; PL113-54: Drug Quality and Security Act; Issues relating to general drug abuse (S. 1277: Combating Prescription Drug Abuse Act) TAX General issues relating to LIFO accounting methodology

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (S. 959, S. 957, H.R. 1919) (H.R. 2186) (H.R. 3204) (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277); Hydrocodone Rescheduling (H.R. 1285, S. 621) Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715)

Client expense: $279,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation and regulation related to medical licensure, telemedicine, medical regulations, license portability, and other matters that might affect state-based health regulation. S.1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013 H.R.2305 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013H.R. 3077 - The TELE-MED Act of 2013 S. 1277 - Combating Prescription Drug Abuse Act H.R. 2484 - Conrad State 30 and Physician Access Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act

Client expense: $520,000 · Firm income: Not reported

**see addendum pageImportation of prescription drugs Drug Abuse (S. 348, H.R. 1285, S. 621, S. 644, S. 1277) Drug Shortages - Gray Market (H.R. 1958) Rx Pedigree (S. 959, S. 957, H.R.1919, H.R. 2186) Prescription Drug Monitoring Program Counterfeit Drugs Drug Take Back (S. 1089)

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (S. 959, S. 957, H.R. 1919) (H.R. 2186) (H.R. 3204); Prescription Drug Monitoring Programs; Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644), Prescription Drug Abuse (S. 1277); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs

Client expense: $285,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

-- S. 621 and HR 1285: Safe Prescribing Act of 2013; -- H.R. 1919: Safeguarding America's Pharmaceuticals Act of 2013; -- H.R. 3204: The Drug Quality and Safety Act; -- S. 957: The Drug Supply Chain Security Act; -- S. 1277: Combating Prescription Drug Abuse Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation and regulation related to medical licensure, telemedicine, medical regulations, license portability, and other matters that might affect state-based health regulation. S.1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013 H.R.2305 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013H.R. 3077 - The TELE-MED Act of 2013 S. 1277 - Combating Prescription Drug Abuse Act H.R. 2484 - Conrad State 30 and Physician Access Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageImportation of prescription drugs Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644), Prescription Drug Abuse (S. 1277) Drug Shortages - Gray Market (H.R. 1958) Rx Pedigree (S. 959, S. 957, H.R. 1919) (H.R. 2186) Prescription Drug Monitoring Program Counterfeit Drugs

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act

Client expense: $540,000 · Firm income: Not reported

S. 621 & H.R. 1285 - Safe Prescribing Act of 2013; H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013; S. 957 & S. 959 - The Drug Supply Chain Security Act; S. 1277- Combating Prescription Drug Abuse Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (S. 959, S. 957, H.R. 1919, H.R. 2186); Prescription Drug Monitoring Programs; Drug Abuse (S. 348); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Prescription Drug Abuse (S. 1277); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs

Client expense: $358,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Ongoing Implementation of EISA RFS2 Program Implementation of Farm Bill Title IX Bioenergy Program for Advanced Biofuels Extension and Reform of Biodiesel Tax Incentive (HR 2388) (S. 1277) Discussion on RIN Integrity Issues.

Client expense: Not reported · Firm income: $90,000

Government targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Navy, Dept of, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

Extension and Reform of Biodiesel Tax Incentive (HR 2388) (S1277).

Client expense: Not reported · Firm income: $90,000

Government targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Navy, Dept of, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

Issues and incentives related to biodiesel, and the Renewable Fuel Standard; S. 1277/H.R. 2238, Biodiesel Tax Incentive Reform and Extension Act; S. 10, Agriculture Reform, Food and Jobs Act; H.R. 8 American Taxpayer Relief Act- extension of biodiesel tax credit.

Client expense: Not reported · Firm income: $20,000

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Issues and incentives related to biodiesel, and the Renewable Fuel Standard; S. 1277/H.R. 2238, Biodiesel Tax Incentive Reform and Extension Act; S. 10, Agriculture Reform, Food and Jobs Act; H.R. 8 American Taxpayer Relief Act- extension of biodiesel tax credit.

Client expense: Not reported · Firm income: $20,000

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Issues and incentives related to biodiesel, and the Renewable Fuel Standard; S. 1277/H.R. 2238, Biodiesel Tax Incentive Reform and Extension Act; S. 10, Agriculture Reform, Food and Jobs Act; H.R. 8 American Taxpayer Relief Act- extension of biodiesel tax credit.

Client expense: Not reported · Firm income: $20,000

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Issues and incentives related to biodiesel, and the Renewable Fuel Standard; S. 1277/H.R. 2238, Biodiesel Tax Incentive Reform and Extension Act; S. 10, Agriculture Reform, Food and Jobs Act; H.R. 8 American Taxpayer Relief Act- extension of biodiesel tax credit.

Client expense: Not reported · Firm income: $20,000

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Issues and incentives related to biodiesel and the Renewable Fuel Standard; S. 1277/H.R. 2238 Biodiesel Tax Incentive Reform and Extension Act; S. 10, Agriculture Reform, Food and Jobs Act; H.R. 8 American Taxpayer Relief Act- extension of biodiesel tax credit.

Client expense: Not reported · Firm income: $20,000

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Issues and incentives related to biodiesel and the Renewable Fuel Standard; S. 1277/H.R. 2238 Biodiesel Tax Incentive Reform and Extension Act; S. 10, Agriculture Reform, Food and Jobs Act; H.R. 8 American Taxpayer Relief Act- extension of biodiesel tax credit.

Client expense: Not reported · Firm income: $20,000

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE